While prior research has shed light on the impact of RB1 inactivation on prostate cancer progression and lineage plasticity, there still remains a critical need to comprehensively understand the underlying mechanisms and identify therapeutic vulnerabilities in RB1-deficient CRPC. The gene discussed is RB1; the disease is prostate cancer.